pharmacy

Based on the bibliometric analysis of scientific publications, patents, Internet resources and previously published results of our own research, the feasibility of developing a new disulfiram composition based on graphite materials with biopolymers was substantiated. Optimal methods were selected and samples of OG-A-DS (graphene oxide-albumin-disulfiram) nanocompositions were obtained in the form of an aqueous dispersion, as well as samples of TRG-BP (thermally expanded graphite-biopolymer) compositions, which will be potential carriers for drugs.

Based on the results of the SWOT-analysis, the prospects and strategy for the development of a homeopathic medicinal product based on ipecacuanha are substantiated. It was found that there is only one domestic complex drug on the pharmaceutical market. It is shown that reduction of the cost and improvement of the quality of the starting material is possible with the use of biotechnological methods. Ultrasonic filtration is proposed to obtain the matrix tincture.

New challenges and the state of development of COVID-19 in connection with the spread of new strains of SARS-CoV-2 have been analyzed. Experience and knowledge in working with new means of protection of different types of vaccines are studied: both classic, based on inactivated virus or its fragment, and the new generation – with vector and genetic mRNA vaccines, as well as effective antiviral drugs. Biorisks and compliance with biosafety principles have been studied.

New challenges and the state of development of COVID-19 in connection with the spread of new strains of SARS-CoV-2 have been analyzed. Experience and knowledge in working with new means of protection of different types of vaccines are studied: both classic, based on inactivated virus or its fragment, and the new generation - with vector and genetic mRNA vaccines, as well as effective antiviral drugs. Biorisks and compliance with biosafety principles have been studied.